BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

7885

524518

KREBSBIO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

KREBS BIOCHEMICALS & IND performance

Today’s low

Today’s high

₹ 81.00 ₹ 84.29
₹ 81.62

52 week low

52 week high

₹ 66.12 ₹ 129.07
₹ 81.62

Open Price

₹ 84.29

Prev. Close

₹ 82.71

Volume (Shares)

2042.00

Total traded value

₹ 1.66

Upper Circuit

₹ 86.84

Lower Circuit

₹ 78.57

info

KREBS BIOCHEMICALS & IND Share Price Update

As of the latest trading session, KREBS BIOCHEMICALS & IND share price is currently at ₹ 81.95, which is down by ₹ -0.76 from its previous closing. Today, the stock has fluctuated between ₹ 81.00 and ₹ 84.29. Over the past year, KREBS BIOCHEMICALS & IND has achieved a return of 4.44 %. In the last month alone, the return has been -12.68 %. Read More...

Investment Returns

Over 1 Month -12.68% Over 3 Months 12.46% Over 6 Months -9.16% Over 1 Year 4.44%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

KREBS BIOCHEMICALS & IND fundamentals


  • Market cap (Cr)

    176.00

  • P/E Ratio (TTM)

    -6.62

  • Beta

    1.16

  • Book Value / share

    -67.82

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -8.27

info icon alternate text
  • Market cap (Cr)

    177.40

  • P/E Ratio (TTM)

    -6.62

  • Beta

    1.02

  • Book Value / share

    -67.82

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -8.27

info icon alternate text

KREBS BIOCHEMICALS & IND Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 6.10
Operating Expense 14.69
Net Profit -8.27
Net Profit Margin (%) -135.57
Earnings Per Share (EPS) -3.83
EBITDA -5.06
Effective Tax Rate (%) -0.24
Particulars DEC 2024 (Values in Cr)
Revenue 11.47
Operating Expense 19.45
Net Profit -7.74
Net Profit Margin (%) -67.48
Earnings Per Share (EPS) -3.59
EBITDA -4.46
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 12.86
Operating Expense 18.70
Net Profit -5.76
Net Profit Margin (%) -44.79
Earnings Per Share (EPS) -2.67
EBITDA -2.63
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 12.89
Operating Expense 18.10
Net Profit -5.17
Net Profit Margin (%) -40.10
Earnings Per Share (EPS) -2.40
EBITDA -2.15
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 11.97
Operating Expense 18.03
Net Profit -5.85
Net Profit Margin (%) -48.87
Earnings Per Share (EPS) -2.72
EBITDA -2.91
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 43.31
Operating Expense 70.94
Net Profit -26.94
Net Profit Margin (%) -62.20
Earnings Per Share (EPS) -12.49
EBITDA -14.32
Effective Tax Rate (%) -0.07
Particulars MAR 2024 (Values in Cr)
Revenue 50.42
Operating Expense 70.60
Net Profit -19.73
Net Profit Margin (%) -39.13
Earnings Per Share (EPS) -9.16
EBITDA -8.27
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 52.13
Operating Expense 77.44
Net Profit -24.69
Net Profit Margin (%) -47.36
Earnings Per Share (EPS) -11.30
EBITDA -15.16
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 59.70
Operating Expense 105.38
Net Profit -44.53
Net Profit Margin (%) -74.58
Earnings Per Share (EPS) -20.81
EBITDA -32.84
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 38.61
Operating Expense 82.68
Net Profit -28.36
Net Profit Margin (%) -73.45
Earnings Per Share (EPS) -14.37
EBITDA -16.95
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -55.29
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.83
EBITDA Margin -16.40
Particulars MAR 2023 (Values in Cr)
Book Value / Share -46.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.78
EBITDA Margin -29.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share -34.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.23
EBITDA Margin -55.01
Particulars MAR 2021 (Values in Cr)
Book Value / Share -23.91
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -31.56
Particulars MAR 2020 (Values in Cr)
Book Value / Share -13.89
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -54.44
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 178.17
Total Liabilities 178.17
Total Equity -119.21
Share Outstanding 21560586
Price to Book Ratio -1.10
Return on Assets (%) -11.07
Return on Capital (%) -26.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 174.98
Total Liabilities 174.98
Total Equity -99.46
Share Outstanding 21560000
Price to Book Ratio -1.22
Return on Assets (%) -14.11
Return on Capital (%) -29.47
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 189.80
Total Liabilities 189.80
Total Equity -75.09
Share Outstanding 21560000
Price to Book Ratio -4.12
Return on Assets (%) -23.45
Return on Capital (%) -65.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 159.22
Total Liabilities 159.22
Total Equity -42.73
Share Outstanding 19620000
Price to Book Ratio -3.72
Return on Assets (%) -17.81
Return on Capital (%) -41.82
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 133.80
Total Liabilities 133.80
Total Equity -24.99
Share Outstanding 18000000
Price to Book Ratio -5.90
Return on Assets (%) -21.57
Return on Capital (%) -71.27
Particulars MAR 2024 (Values in Cr)
Net Income -19.72
Cash from Operations 2.30
Cash from Investing -7.81
Cash from Financing 5.56
Net change in Cash 0.05
Free Cash Flow 11.71
Particulars MAR 2023 (Values in Cr)
Net Income -24.69
Cash from Operations -24.71
Cash from Investing -12.64
Cash from Financing 37.34
Net change in Cash -0.01
Free Cash Flow -9.55
Particulars MAR 2022 (Values in Cr)
Net Income -44.52
Cash from Operations -17.21
Cash from Investing -22.89
Cash from Financing 39.50
Net change in Cash -0.61
Free Cash Flow 9.86
Particulars MAR 2021 (Values in Cr)
Net Income -28.35
Cash from Operations -14.57
Cash from Investing -22.54
Cash from Financing 37.66
Net change in Cash 0.53
Free Cash Flow 3.18
Particulars MAR 2020 (Values in Cr)
Net Income -28.87
Cash from Operations -35.49
Cash from Investing -10.22
Cash from Financing 28.57
Net change in Cash -17.14
Free Cash Flow -26.79
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.44 32.25 1.99 279.25 34.11 / 77.70
BLISS GVS PHARMA LTD 153.75 19.24 1.54 1621.22 105.05 / 184.95
CIPLA LTD 1477.30 23.19 3.82 119322.68 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 374.05 14.32 3.03 1100.87 189.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 3250.05 63.00 28.21 55057.81 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.19 92.79 5.71 277.34 34.11 / 77.70
AMRUTAJAN HEALTH LTD 717.40 40.81 6.35 2074.05 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 9296.00 132.76 30.16 23240.00 6222.35 / 10653.05
BLISS GVS PHARMA LTD 155.40 23.76 1.54 1638.62 105.05 / 184.95

KREBS BIOCHEMICALS & IND Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
81.62 -1.31 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 84.40
  • 26 Days 85.70
  • 10 Days 85.50
  • 50 Days 84.10
  • 12 Days 85.80
  • 100 Days 83.50
  • 20 Days 86.10
  • 200 Days 83.70
82.82 PIVOT

First Support

80.89

First Resistance

84.63

Second Support

79.08

Second Resistance

86.56

Third Support

77.15

Third Resistance

88.37

RSI

43.53

ADX

29.09

MACD

0.05

Williams % R

-84.31

Commodity Channel Index (CCI)

-194.14

Date

2025-06-16

Week

49757.00

Same Day

51347.00

Month

20425.00

1 Year

1.16

3 Year

0.94

Over 1 Month

-12.68%

down

Over 1 Year

4.44%

down

Over 3 Months

12.46%

down

Over 3 Years

-7.08%

down

Over 6 Months

-9.16%

down

Over 5 Years

2.15%

down

KREBS BIOCHEMICALS & IND shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
26.75%
Promoter Holdings
72.74%
FII
0.49%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Ipca Laboratories Limited 1.0705195E7 (49.65%) Shareholding of Promoter and Promoter Group
Hemalatha Ravi 2691524.0 (12.48%) Shareholding of Promoter and Promoter Group
Avinash Ravi 2140272.0 (9.93%) Shareholding of Promoter and Promoter Group
Sun Pharmaceutical Industries Ltd 1036943.0 (4.81%) Public Shareholding
Guttikonda Rajasekhar 401694.0 (1.86%) Public Shareholding
Guttikonda Vara Lakshmi 367094.0 (1.7%) Public Shareholding
Ajay Ravi 112997.0 (0.52%) Shareholding of Promoter and Promoter Group
Dr R T Ravi 23474.0 (0.11%) Shareholding of Promoter and Promoter Group
Aditya Ravi 10672.0 (0.05%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

KREBS BIOCHEMICALS & IND corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

KREBS BIOCHEMICALS & IND Share Price

Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same.

Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry. Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies.

KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994.

During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

The Company commissioned 2.5 MW Co-generation Power Plant at Unit II in Vizag during 2003-04 and started operations on it from July, 2004 onwards.

Parent organization Indian Private
NSE symbol KREBSBIO
Founded 1991
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Krebs Biochemicals & Industries Ltd?

Answer Field

Krebs Biochemicals & Industries Ltd share price is for NSE ₹ 81.95 & for BSE ₹ 82.26 as on Jul 11 2025 03:28 PM.

What is the Market Cap of Krebs Biochemicals & Industries Ltd Share?

Answer Field

The market cap of Krebs Biochemicals & Industries Ltd for NSE ₹ 176.00 & for BSE ₹ 0.00 as on Jul 11 2025 03:28 PM.

What is the 52 Week High and Low of Krebs Biochemicals & Industries Ltd?

Answer Field

The 52 Week High and Low of Krebs Biochemicals & Industries Ltd for NSE is ₹ 129.07 and ₹ 66.12 and for BSE is ₹ 129.00 and ₹ 63.55.

What is 1 year return for Krebs Biochemicals & Industries Ltd?

Answer Field

The 1 year returns on the stock has been 4.44%.

What is the P/E Ratio of Krebs Biochemicals & Industries Ltd Share?

Answer Field

As on Jul 11 2025 03:28 PM the price-to-earnings (PE) ratio for Krebs Biochemicals & Industries Ltd share is -6.62.

What is the PB ratio of Krebs Biochemicals & Industries Ltd Share?

Answer Field

As on Jul 11 2025 03:28 PM, the price-to-book (PB) ratio for Krebs Biochemicals & Industries Ltd share is -67.82.

How to Buy Krebs Biochemicals & Industries Ltd Share?

Answer Field

You can trade in Krebs Biochemicals & Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Krebs Biochemicals & Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Krebs Biochemicals & Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Krebs Biochemicals & Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|